Researchers at TauRx Therapeutics – a leader in Alzheimer’s disease research – are using the automation capabilities of multiple Atlas HD reactor systems and Atlas Syringe Pumps to simplify and accelerate process development of active pharmaceutical ingredients (APIs) for its product pipeline.

A picture of TauRX's lab showcasing the Atlas HD systems and Atlas Syringe Pumps - Walk-away API process development for TauRX with Syrris Atlas HD
A picture of TauRX's lab showcasing the Atlas HD systems and Atlas Syringe Pumps - Walk-away API process development for TauRX with Syrris Atlas HD
A picture of TauRX's lab showcasing the Atlas HD systems and Atlas Syringe Pumps - Walk-away API process development for TauRX with Syrris Atlas HD
A picture of TauRX's lab showcasing the Atlas HD systems and Atlas Syringe Pumps - Walk-away API process development for TauRX with Syrris Atlas HD

Based at the company’s primary research facilities at the University of Aberdeen, Scotland, the Atlas HD automated reactor systems and Atlas Syringe Pumps have become an integral part of the quality by design (QBD) process optimization workflow. Process Chemist, Scott Clunas, explained:

“We have been using Syrris’ Altas Syringe Pumps and software for a number of years. This combination of pumps and automation software is very flexible, allowing us to add multiple reagents to a reactor vessel at set intervals, without needing to have somebody at the bench to manually add liquids or swap lines.

We have been very happy with the robustness and performance of the pumps, so when we were looking to invest in additional batch reactor systems, Syrris was the logical choice.

Scott Clunas, Process Chemist

“We have been very happy with the robustness and performance of the pumps, so when we were looking to invest in additional batch reactor systems, Syrris was the logical choice.

“We now have four Atlas HD jacketed reactor systems – set up as two parallel pairs each controlled by a single PC – allowing us to more quickly and easily perform QBD studies for the production of our active pharmaceutical ingredients. Each of these experiments can run for 24 to 48 hours, so it’s essential that we can automate the entire reaction. The Atlas reactor systems ensure that each experiment is performed in exactly the same way every time – eliminating the variability associated with manual processes – giving us a very high degree of process control for consistent results and, ultimately, more robust processes,” Scott concluded.


Further reading on chemistry automation

Have a specific question about automating your chemistry, or want to know more about Atlas HD or any other Syrris products? Fill in our contact form and a member of the Sales team will be in touch.